 |
Nuvalent
Last updated: January 16, 2024
Founder Matthew Shair
Country: USA | Funding: $749.5M (+)
Website: https://www.nuvalent.com/
Nuvalent is a biotechnology company that develops targeted therapies for clinically proven kinase targets in cancer.
Website: https://www.nuvalent.com/
Nuvalent is a biotechnology company that develops targeted therapies for clinically proven kinase targets in cancer.
